Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï ÄÚ¿¢½º B1 ´ÙÀ̾Ƹóµå·ë
±³À°ÁÖÁ¦ : Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ±èÈ£Á¤
¿¬¶ôó : 055-910-2187
À̸ÞÀÏ : ksimd2014@naver.com
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í "»çÀüµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 4¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 3¸¸¿ø, ±âŸ 4¸¸¿ø
»çÀüµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 6¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 5¸¸¿ø, ±âŸ 6¸¸¿ø
ÇöÀåµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 4¸¸¿ø, ±âŸ 5¸¸¿ø
ÇöÀåµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 7¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 6¸¸¿ø, ±âŸ 7¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:00~10:40 Transforming the Newborn Screening Program in Tokyo: Improving Children Kimihiko Oishi(Chair and Professor of the Department of Pediatrics at the Jikei University School of Medicine)
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 10:40~11:20 Health care transition from pediatric to adult care for the patients of inherited metabolic diseases Mitsuru Kubota(ational Center for Child Health and Development, Japan)
ÈÞ½Ä 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:20~11:30 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 11:30~12:00 Phase I,II,III clinical trial of idursulfatase beta in Hunter syndrome; from the beginning to the end Áøµ¿±Ô(³ëº§Æĸ¶)
±³À°½Ã°£ 06¿ù 28ÀÏ 12:00~12:30 Translational and clinical development of cell therapy for Charcot-Marie-Tooth type I disease Á¤¼ºÃ¶(ÀÌÈÀÇ´ë)
½Ä»ç 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 12:30~13:30 ½Ä»ç ()
±âŸ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 13:30~14:30 oral presentation(Japan & Korea) ()
ÈÞ½Ä 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 14:30~14:50 Break Time & Poster rounding ()
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 14:50~15:20 Recognition of alpha mannosidosis - How to diagnose and how to treat Christina Lampe(University Hospital of Giessen, Germany)
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:20~15:50 Pediatric phenylketonuria: ex-vivo cell therapy Á¤Àç¹Î(¼¿ï¿©´ë)
ÈÞ½Ä 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 15:50~16:00 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:00~16:20 Treatment and management strategies for primary mitochondrial disease ³ªÁöÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:20~16:40 Pre-implantation Genetic Testing in primary mitochondrial disease ¿ÀÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ïÄÚ¿¢½º ´ÙÀ̾Ƹóµå·ë 16:40~17:00 Chaperone therapy in IMD À̹üÈñ(¿ï»êÀÇ´ë)